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VCP-dependent muscle degeneration is
linked to defects in a dynamic tubular
lysosomal network in vivo
Alyssa E Johnson, Huidy Shu, Anna G Hauswirth, Amy Tong, Graeme W Davis*
Department of Biochemistry and Biophysics, University of California, San Francisco,
San Francisco, United States
Abstract Lysosomes are classically viewed as vesicular structures to which cargos are delivered
for degradation. Here, we identify a network of dynamic, tubular lysosomes that extends throughout
Drosophila muscle, in vivo. Live imaging reveals that autophagosomes merge with tubular lysosomes
and that lysosomal membranes undergo extension, retraction, fusion and fission. The dynamics and
integrity of this tubular lysosomal network requires VCP, an AAA-ATPase that, when mutated, causes
degenerative diseases of muscle, bone and neurons. We show that human VCP rescues the defects
caused by loss of Drosophila VCP and overexpression of disease relevant VCP transgenes dismantles
tubular lysosomes, linking tubular lysosome dysfunction to human VCP-related diseases. Finally,
disruption of tubular lysosomes correlates with impaired autophagosome-lysosome fusion, increased
cytoplasmic poly-ubiquitin aggregates, lipofuscin material, damaged mitochondria and impaired
muscle function. We propose that VCP sustains sarcoplasmic proteostasis, in part, by controlling the
integrity of a dynamic tubular lysosomal network.
DOI: 10.7554/eLife.07366.001
Introduction
Valosin-containing protein (VCP), the homologue of yeast Cdc48, is the causative gene for a multisystem
degenerative disease that was originally termed IBMPFD to encompass the wide range of debilitating
clinical outcomes, including inclusion body myopathy (IBM), Paget’s disease of the bone (PDB) and
frontotemporal dementia (FD) (Watts et al., 2004). Recently, the list of degenerative disorders that are
associated with VCP mutations has expanded to include amyotrophic lateral sclerosis (ALS)
(Abramzon et al., 2012), spastic paraplegia (Clemen et al., 2010), scapuloperoneal muscular dystrophy
(Liewluck et al., 2014) and Charcot-Marie-Tooth disease (Gonzalez et al., 2014). Currently, there are
no viable treatments available to slow or halt progression of VCP-related diseases.
Muscle weakness is the first presenting symptom in over 50% of VCP disease patients (Weihl et al.,
2009), yet very little is known about the muscle pathology of VCP-related diseases. Muscle biopsies
from patients with VCP-related diseases display an accumulation of cytoplasmic poly-ubiquitin
aggregates (Watts et al., 2004; Weihl et al., 2009; Dolan et al., 2011), suggesting a major defect in
protein clearance. VCP is an AAA-ATPase that has essential functions in ubiquitin-dependent
proteolysis. But, pathogenic mutations in VCP do not seem to impair the UPS or ERAD protein
degradation pathways (Tresse et al., 2010a; Chang et al., 2011). More recently, VCP has been
implicated in autophagy. Specifically, over-expression of VCP mutant transgenes with disease causing
mutations leads to an accumulation of autophagosomes (Ju et al., 2009; Tresse et al., 2010a),
suggesting that VCP functions in processes related to the maturation or fusion of autophagosomes
with lysosomes.
Lysosomes are the major cellular degradation sites for clearing damaged proteins and organelles.
Lysosomes are classically thought to be vesicular organelles, where they serve as depots for cargo
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delivered via endosomes or autophagosomes. However, in certain systems lysosomes have been
observed to adopt non-vesicular morphologies. A particularly dramatic example has been observed in
a subset of bone-derived cultured macrophages, where lysosomes form abundant, extended tubules
that radiate from the cell center and, in some cases, form an interconnected web throughout the
cytoplasm (Swanson et al., 1987a; Knapp and Swanson, 1990). Additionally, there are examples
where cellular stress, particularly the induction of high levels of autophagy, induces lysosomal
membranes to tubulate and undergo scission to produce new vesicular lysosomes, a process referred
to as autophagic lysosome reformation (ALR) (Yu et al., 2010). Despite these observations, lysosome
tubules have received little attention and it remains unclear to what extent lysosome tubulation occurs
in different cell types and what purpose it serves in vivo. Moreover, the molecular repertoire of factors
required for lysosome tubule formation is virtually unknown.
Here, we employ fluorescently tagged lysosomal and autophagic markers to study the autophagy-
lysosome system in Drosophila muscle cells and investigate the muscle pathology of VCP-related
diseases. Remarkably, we find that lysosomes adopt a dynamic, tubular morphology that ramifies
throughout the entire sarcoplasm of Drosophila muscle, in vivo. We find that VCP is required for the
integrity and dynamics of this tubular network. Disruption of lysosome tubules correlates with defects
in autophagosome-lysosome fusion, increased poly-ubiquitin aggregates and the accumulation of
lipofuscin material in the sarcoplasm. We show that the human VCP homolog can rescue lysosomal
tubulation following loss of VCP in Drosophilamuscle, indicating that the functions of VCP in lysosome
tubulation are conserved. Finally, we demonstrate that homologous mutations that cause VCP
diseases in human patients disrupt the lysosome tubular lattice, suggesting that disruption of
eLife digest Mutations in a gene that produces a protein called Valosin-containing protein (VCP
for short) causes degenerative diseases that affect the brain, muscle and bone. In nearly half of the
individuals with these VCP-related diseases—which can also result in dementia, Paget’s disease of
the bone and amyotrophic lateral sclerosis (ALS)—the first symptom is muscle weakness. Currently,
very little is known about how VCP affects muscles.
Patients with VCP-related diseases often have problems clearing damaged proteins from their
cells, and recent research suggests that VCP is important for forming a cellular structure known as
a lysosome. Lysosomes contain powerful enzymes that destroy damaged proteins and other cellular
structures that would otherwise accumulate in the cells. In most cells, lysosomes look like bubble-like
compartments called vesicles. However, in some types of cells lysosomes have been observed to
form a network of tubules that extend throughout the cell interior. However, it remains unclear what
these tubules do, how they form in cells and whether they are altered in disease.
Johnson et al. analyzed lysosomes in the muscle of the fruit fly species Drosophila melanogaster
and discovered that lysosomes were in the form of a network of tubules that spread throughout each
muscle cell. These tubules constantly changed in living muscles; extending, retracting, breaking and
merging to form a large tubular lysosome network. When Johnson et al. reduced the amount of VCP
produced by the muscle cells, via a method called RNA interference, the lysosome tubules broke
down into vesicles that were no longer constantly changing. Modifying these defective fly muscle
cells so that they produced the human VCP protein caused the tubules to form again. These results
suggest that the human and fly VCP proteins are very similar and that they play a key role in either
the ability of lysosomes to form tubules or the maintenance of existing tubules.
Johnson et al. then engineered flies to produce a version of the VCP protein that had mutations
commonly seen in individuals with degenerative diseases. Lysosome tubules did not form correctly in
the muscle cells of these flies. These flies also had other abnormalities; for example, their cells
showed a great build-up of damaged proteins, and their ability to move their muscles was weaker.
These findings suggest that a network of lysosomal tubules is necessary for healthy muscle cells,
but how and why these tubular networks are formed or maintained is still mysterious. What causes
lysosomal membranes to form tubules? How do they break and fuse? And why are they necessary?
Genetic experiments in fruit flies will be a great place to discover these mechanisms and understand
the links to degenerative diseases in humans.
DOI: 10.7554/eLife.07366.002
Johnson et al. eLife 2015;4:e07366. DOI: 10.7554/eLife.07366 2 of 20
Research article Cell biology | Neuroscience
lysosome tubules contributes to VCP mutant pathogenesis. Taken together, our data establish
a functional link between lysosome tubule dysfunction and the pathology of VCP-related degenerative
diseases.
Results
Drosophila sarcoplasmic lysosomes form an extended dynamic tubular
array in vivo
To visualize muscle lysosomes in vivo, we expressed RFP-tagged Spinster, which has previously been
defined as a late endosomal/lysosomal transmembrane protein (Sweeney and Davis, 2002; Dermaut
et al., 2005). Remarkably, when Spinster-RFP is expressed in Drosophila muscle, Spin-RFP localizes to
an expansive tubular network (Figure 1A–C and Video 1). Tubules were found evenly distributed
throughout the sarcoplasm and formed a web of connections with other tubules (Figure 1B,C).
Tubules were observed in every muscle and there were no apparent differences in the tubule
abundance or architecture between different muscles. We also observed enlarged vesicular
compartments at tubule intersections throughout the muscle (Figure 1C). This network is highly
sensitive to all chemical fixation conditions that we have attempted. When subjected to fixation, the
tubule lattice collapses (Figure 1D), leaving behind distributed round, Spinster-positive compart-
ments that resemble classically defined late-endosomal, lysosomal structures (Sweeney and Davis,
2002; Dermaut et al., 2005). Thus, live imaging is essential to study the function and relevance of this
Spin-positive, tubular network.
We next explored the dynamics of this tubular network in time-lapse videos. We find evidence of
tubule extension, retraction, scission and fusion (Figure 1E–G). The dominant activity in the network is
the dynamic extension and retraction of individual tubules throughout the sarcoplasm (Figure 1E and
Video 2). Often the same tubule was observed to extend and retract, while surrounding tubules
remained constant. The impression is that the lattice has both stable, interconnected tubules and
dynamic elements that create new connections or retract once a connection is broken. In less frequent
instances, we observed scission events from the end of a tubule, resulting in a mobile vesicle
(Figure 1F). In a corollary phenomenon, we observed tubule extensions that resulted in tubules fusing
to larger nodes in the network (Figure 1G). Finally, we observed de novo formation of tubules
extruding from the side of existing tubules (Figure 1G, last panel) demonstrating that tubulation can
originate from existing tubules, not just pre-existing nodes. Importantly, the existence of a tubular
network and tubule dynamics are not an artifact of a dissected neuromuscular preparation. We
observed an identical, dynamic tubular lysosomal network in intact larvae that were imaged through
the cuticle while restrained in a microfluidics chamber (Video 3).
The observed lysosomal network structure and dynamics are consistent with the involvement of
either the actin or microtubule cytoskeletons. First, we tested whether the tubules require an intact
microtubule cytoskeleton. Treatment with nocodazole for 1 hr completely abolished tubules,
indicating that the tubules require microtubule support (Figure 1H,I). In contrast, disruption of the
actin cytoskeleton with latrunculin A did not have a significant effect on the tubular network,
indicating a non-essential role for the actin cytoskeleton in maintaining lysosome tubules (Figure 1J).
Finally, we tested whether Clathrin is essential for tubular network integrity. Clathrin has the capacity
to shape membranes and was recently implicated in the process of ALR in cultured mammalian cells
(Rong et al., 2012), a process that involves limited tubulation from auto-lysosomal compartments.
Expression of Clathrin heavy chain RNAi (Chc-RNAi) completely disrupted network integrity
(Figure 1K).
Although Spinster was characterized previously as a lysosomal marker, the tubular structures
labeled by Spinster are dramatically different from the classical view of vesicular lysosomes. Therefore,
we performed additional experiments to validate that the tubular network is lysosomal. First, we co-
imaged Spin-GFP with the low pH fluorescent probe Lysotracker and found complete co-localization
(Figure 2A), indicating that the Spinster network is acidic. To verify that the observed tubular network
is not an artifact of Spin-RFP over-expression, we stained wild type muscles with Lysotracker to
examine lysosome morphology under wild type conditions. Lysotracker staining confirmed the
existence of this tubular network in wild type muscle (Figure 2B). We also note that the tubule
intersections stained more intensely for Lysotracker than the tubules themselves. This could be due to
increased tubule volume at the intersections, or these sites might actually have a lower pH than the
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tubules themselves. Finally, we co-imaged Spin-RFP with several other organelle markers to verify that
Spinster specifically labels lysosomes and does not co-stain other organelles. ER and mitochondria
also form tubule structures, but when we co-imaged Spin-RFP with ER-tracker and Mito-tracker
fluorescent dyes, Spin-RFP tubules did not co-localize with either ER or mitochondria tubules
(Figure 2C,D). Instead, Spin-RFP tubules were interwoven between mitochondria and ER tubules.
Additionally, Spin-RFP did not co-localize with markers for early endosomes (YFP-Rab5), recycling
endosomes (Rab11-GFP), medial Golgi (ManII-GFP) or trans Golgi (GalT-YFP) (Figure 2E–H). We note
that Golgi organization in muscles forms vesicular structures rather than the classical Golgi stacks that
are observed in most cell types and this is consistent with Golgi organization that has been observed
in vertebrate skeletal muscles (Ralston et al., 2001). Collectively, we have identified and characterized
Figure 1. Lysosomes adopt an extended dynamic tubular array in Drosophila sarcoplasms. (A) Muscles of third instar
larvae from segment A2. (B) Representative live image of Spin-RFP expressed in muscles at 63× magnification.
Muscle 4 (B) is shown. DNA was stained with Hoescht. (C) Representative live image of Spin-RFP expressed in
muscles using the muscle-specific MHC-Gal4 driver. DNA was stained with Hoescht. (D) Representative image of
Spin-GFP localization in a muscle that was fixed with 4% PFA prior to imaging. (E) Time-lapse images of the Spin-RFP
network. Time 0 is represented in magenta, and the 5 min time-point is represented in green. The 2 time points were
merged to show new and lost tubule formations over the course of 5 min. Arrows indicate examples of de novo
tubule formations and the asterisk indicates a retracted tubule. (F) Representative time-lapse sequence of a Spin-
GFP tubule fission event. (G) Representative time-lapse sequence of a Spin-GFP tubule fusion event. In the last
frame, a de novo tubule can be seen extruding from the middle of a pre-existing tubule. (H–J) Spin-RFP localization
in muscles treated with DMSO (H), Nocodazole (I) or LatA (J). (K) Spin-RFP localization in muscles expressing Clathrin
heavy chain (Chc) RNAi.
DOI: 10.7554/eLife.07366.003
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a dynamic tubular lysosomal network that per-
meates the entire sarcoplasm of Drosophila
body-wall muscle in vivo.
VCP is required for the integrity and dynamics of the extended tubular
lysosomal network
To investigate the molecular underpinnings of the observed lysosomal tubule dynamics, we pursued
a candidate-based RNAi screen to identify genes required for lysosome tubulation. We focused on
genes that have been implicated in the autophagy-lysosome system and identified the AAA-ATPase
VCP as being required for the integrity of the entire tubular lysosome network. Specifically,
inhibiting VCP expression by RNAi abolished lysosome tubules, leaving behind vesicles throughout
the sarcoplasm (Figure 3A,B). The lysosome vesicles were irregular in their size and shape and
appeared clustered, rather than uniformly distributed throughout the sarcoplasm. To determine
whether the catalytic ATPase function of VCP is required for the tubular network integrity, we
employed a VCP-selective inhibitor DBeQ (Chou et al., 2011). Acute inhibition of VCP with DBeQ
completely disrupted the tubular network after
3 hr (Figure 3C,D), demonstrating the required
catalytic function of VCP. Furthermore, time-
lapse imaging of Spin-GFP after treatment with
DBeQ for 4 hr revealed that the remaining
vesicular lysosome structures are completely
static (Video 4).
To determine if the role of VCP in maintaining
the tubular lysosomal network in muscle cells is
conserved, we overexpressed human VCP in
dVCPRNAi muscles. Human VCP should be com-
pletely resistant to dVCPRNAi due to lack of
extended stretches of nucleotide identity. Over-
expressing human VCP in dVCPRNAi muscles
rescued the formation of lysosome tubules in
every muscle (Figure 3E–G). These rescue data
confirm that VCP knockdown is the cause of
disrupted lysosomal network integrity and dem-
onstrate that VCP-dependent activity is con-
served in the human VCP protein.
Video 1. Spin-RFP tubular network in Drosophila
muscle. Spin-RFP was expressed in muscles and
imaged live. Average Z-stacks were assembled to
produce a 3D volume projection and various angles of
the projections are shown.
DOI: 10.7554/eLife.07366.004
Video 2. Spin-RFP tubule dynamics in Drosophila
muscle. Representative time-lapse video of Spin-RFP
expressed in muscles. Frames were taken at 10 s
intervals.
DOI: 10.7554/eLife.07366.005
Video 3. Spin-RFP tubule dynamics in an intact larva. A
whole un-dissected larva was immobilized in a mircro-
fluidics chamber and Spin-RFP was imaged in the body-
wall muscle through the transparent cuticle. Frames
were taken at 10 s intervals.
DOI: 10.7554/eLife.07366.006
Johnson et al. eLife 2015;4:e07366. DOI: 10.7554/eLife.07366 5 of 20
Research article Cell biology | Neuroscience
Figure 2. Spin-RFP tubules do not co-localize with mitochondria, ER, golgi or early endosomes. (A) Co-imaging of
Spin-GFP and Lysotracker Red staining. (B) Lysotracker staining of wild type muscles. (C–H) Co-imaging of Spin-RFP
with ER tracker (C), Mito tracker (D), YFP-Rab5 (E), Rab11-GFP (F), ManII-GFP (G), GalT-YFP (H).
DOI: 10.7554/eLife.07366.007
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Since VCP knockdown destroys the sarcoplasmic tubular lysosomal network prior to obvious
cellular degeneration, we speculated that dismantling of the network could be a precursor to cellular
degeneration. However, it is also possible that loss of this network is a secondary correlate of
impaired muscle health. To address this issue, we examined two additional RNAi-mediated
conditions that cause muscle degeneration, looking for the presence or absence of tubular
lysosomes. Specifically, we expressed RNAi against parkin and tbph, Drosophila orthologues of
genes linked to Parkinson’s and ALS, respectively. These RNAi have been shown to cause muscle
degeneration in Drosophila (Diaper et al., 2013; Cornelissen et al., 2014). Remarkably, we did not
observe any significant effect on lysosome tubules (Figure 3H–J) when parkin-RNAi and tbph-RNAi
are expressed with BG57-Gal4, the same Gal4 line used to express VCP-RNAi throughout our
studies.
VCP has well-established roles in the ERAD pathway and loss of VCP causes ER stress (Wo´jcik
et al., 2006). Thus, it is possible that loss of tubular lysosomes is caused indirectly by ER stress. To
address this possibility, we treated muscles with tunicamycin (TM) to induce ER stress by another
Figure 3. VCP inhibition disrupts the lysosome tubule lattice and human VCP rescues this defect. (A) Representative
live image of Spin-RFP expressed in muscle using the muscle-specific BG57-Gal4 driver. (B) Live image of Spin-RFP
in muscles expressing VCP-RNAi using the muscle-specific BG57-Gal4 driver. (C, D) Live images of Spin-RFP
expressed in muscles that were treated with DMSO (C) or the VCP-specific inhibitor DBeQ (D) for 4 hr. (E) Live image
of Spin-GFP expressed in muscles using the muscle-specific BG57-Gal4 driver. (F) Live image of Spin-GFP in muscles
expressing VCP-RNAi using the muscle-specific BG57-Gal4 driver. (G) Live image of Spin-GFP in muscles that co-
express VCP-RNAi and human VCP (hVCP) using the muscle-specific BG57-Gal4 driver. (H–J) Lysotracker staining in
wild type (H) muscles or muscles expressing parkin-RNAi (I) or tbph-RNAi (J). (K, L) Spin-RFP localization in muscles
treated with DMSO (K) or tunicamycin (TM) (L). (M) Western blot analysis of total Hsc70/BiP protein levels. Tubulin
serves as a loading control.
DOI: 10.7554/eLife.07366.008
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means and examined the tubular network. Upon
treatment with TM for 4 hr, the Spin-RFP tubular
network remained intact (Figure 3K,L). We
verified that ER stress was induced by examining
levels of Hsc70/BiP, a marker of ER stress, in
protein lysates derived from the same animals
that were used for imaging. Total protein levels
of Hsc70/BiP were significantly increased in both
TM and DBeQ treated muscles (Figure 3M).
Thus, tubular network disruption is not a byprod-
uct of ER stress. Taken together, our data
are consistent with three conclusions: (1) VCP
loss of function disrupts the integrity of the
tubular lysosomal network, (2) the role of VCP
in maintaining tubular lysosomes is conserved
and (3) disruption of the tubular network is
specific for VCP loss of function and not
a secondary byproduct of muscle degeneration
or ER stress.
Autophagosome membranes co-localize with the tubular lysosome
network
Muscle biopsies from patients with VCP-related disease display an accumulation of cytoplasmic poly-
ubiquitin aggregates (Watts et al., 2004;Weihl et al., 2009; Dolan et al., 2011), suggesting a defect
in protein clearance. This led us to explore the intersection of the observed tubular lysosomal network
and autophagy. First, we co-imaged Spin-GFP with the autophagosome membrane marker mCherry-
Atg8a/LC3 to determine the relationship between autophagosomes and the tubular lysosome
network. Remarkably, we find that mCherry-Atg8a precisely co-localizes with Spin-GFP-labeled
tubules (Figure 4A). The mCherry-Atg8a labeling is widely distributed within the network, but does
not label the full extent of every tubule (Figure 4A). Time-lapse imaging revealed mCherry-Atg8a
labeling is dynamic within Spin-GFP tubules (Video 5). Some mCherry-Atg8a puncta appear to traffic
through the Spin-GFP tubules suggesting that autophagosome membranes and/or cargos are
dynamic within the tubular lysosome network (Figure 4B). Atg8 localizes to the autophagophore
membrane prior to the formation of an enclosed autophagosome, at which point Atg8 is shed from
the outer autophagosome membrane (Xie and Klionsky, 2007). After autophagosomes fuse with
lysosomes, lysosomal enzymes degrade the inner autophagosome membrane containing Atg8 (Xie
and Klionsky, 2007). Given this sequence of events, we propose that the mCherry-Atg8a positive
regions of the lysosome tubules represent ongoing degradation of autophagosome membranes
following fusion with the Spin-GFP positive lysosomal network.
Next, we explored the consequence of disrupting VCP activity on Atg8 and Spin-GFP co-
localization. When VCP was knocked down and the tubular-lysosomal network was eliminated, Atg8
no longer co-localized with Spin-GFP (Figure 4C). Rather, Atg8-positive vesicles were found closely
apposed to Spin-positive, vesicular lysosomal compartments. This close apposition suggests that the
autophagosomes can identify and potentially dock against the lysosomal membranes, but fusion of
the autophagosome with the lysosome is defective. This is consistent with an established role for the
yeast VCP homolog, Cdc48, in membrane fusion (Latterich et al., 1995).
To test whether tubules that are positive for both mCherry-Atg8a and Spin-GFP are, indeed,
a consequence of fused auto-lysosomes, we imaged a dual fluorescent reporter GFP-mCherry-Atg8a
(Nezis et al., 2010). In neutral pH conditions, both GFP and mCherry fluoresce. However, in acidic
environments such as in the lysosomal lumen, GFP fluorescence is quenched and only mCherry is
observed. Thus, autophagosomes that are fused with lysosomes will exhibit mCherry but not GFP
fluorescence. It is important to note that Spin-GFP fluorescence is not quenched because the
C-terminal GFP tag resides on the cytoplasmic face of lysosomes (Dermaut et al., 2005). When we
expressed the dual fluorescence reporter in muscles we found no detectable GFP fluorescence in the
tubules that label strongly for mCherry-Atg8a (Figure 4D), consistent with other data indicating that
Video 4. Spin-GFP dynamics in muscles expressing
VCP-RNAi. Representative time-lapse video of Spin-GFP
in muscles expressing VCP-RNAi. Frames were taken at
10 s intervals.
DOI: 10.7554/eLife.07366.009
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the tubules are acidic. To further test the acidic nature of the tubules, we treated muscles with
concanamycin A, a specific inhibitor of the lysosomal V-ATPase that is required for lysosome
acidification (Huss et al., 2002). Upon treatment with ConA for 3 hr, we observed GFP and mCherry
positive tubules (Figure 4E). Together, these data further verify that the lysosome tubules are acidic
and also demonstrate that acidification is not necessary to maintain the structure of the tubules.
Again, we explored the consequence of disrupting VCP activity. Inhibiting VCP function with DBeQ
created GFP-positive vesicles (Figure 4F) that must be non-acidified compartments, a finding that is
consistent with the existence of autophagosomes that have not yet fused with Spin-positive
lysosomes. Since the appearance of GFP-positive vesicles occurs in a time frame of minutes to hours, it
Figure 4. Autophagosomes co-localize with the tubular lysosomal network. (A) Representative live image of Spin-
GFP and mCherry-Atg8a co-expressed in muscles using the muscle-specific BG57-Gal4 driver. (B) Representative
time-lapse sequence of Spin-GFP and mCherry-Atg8a in muscle. The arrow follows a mCherry-Atg8a positive puncta
trafficking along a Spin-GFP tubule. (C) Spin-GFP and mCherry-Atg8a no longer co-localize in muscles expressing
VCP-RNAi. White box indicates region shown at higher magnification and separate channels at right. D. Live image
of GFP-mCherry-Atg8a in muscles treated with DMSO for 3 hr. Note the lack of GFP signal. (E) Live image of GFP-
mCherry-Atg8a in muscles treated with the V-ATPase specific inhibitor Concanamycin A (ConA) for 3 hr. Note the
presence of GFP-positive tubules. (F) Live image of GFP-mCherry-Atg8a in muscles treated with the VCP-specific
inhibitor DBeQ for 3 hr. Note the presence of GFP-positive vesicles. (G) Spin-RFP localization in WT muscles or
muscles expressing Atg7-RNAi using the muscle specific BG57-Gal4 driver.
DOI: 10.7554/eLife.07366.010
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suggests that there is a continual flux of material
through the auto-lysosomal system in muscle
cells at steady state.
Finally, we examined whether autophagy in-
flux was required to induce or maintain lysosome
tubules. Expression of Atg7-RNAi, an RNAi line
that has been shown previously to inhibit
autophagosome assembly (Ren et al., 2009),
did not affect lysosome tubules (Figure 4G).
Thus, autophagy induction is not a prerequisite
for lysosome tubules. Taken together, these data
confirm previous reports that VCP is required for
autophagosome-lysosome fusion (Tresse et al.,
2010b) and further suggest that VCP loss
abrogates autophagosome-lysosome fusion by
affecting the structural properties of lysosomes.
VCP localizes to auto-lysosomes
Previous studies have reported that, when over-
expressed in cultured cells, mammalian VCP
localizes diffusely at the nucleus and throughout
the cytoplasm (Vesa et al., 2009; Tresse et al., 2010a; Wang et al., 2011). To examine VCP
localization in live muscles, we generated a UAS-VCP-Venus transgenic fly. Similar to previous reports
for mammalian VCP, we observed abundant VCP localization in and around the nucleus and diffusely
in the cytoplasm (Figure 5—figure supplement 1). But, VCP-Venus also concentrated at structures
that are labeled by either Spin-RFP (Figure 5A) or mCherry-Atg8a (Figure 5B), demonstrating that
VCP localizes to auto-lysosomes.
Because inhibiting the catalytic function of VCP leads to tubule deterioration, we tested whether
inhibiting the catalytic function of VCP would affect its localization to auto-lysosomes. Surprisingly,
inhibiting VCP activity with DBeQ for 2 hr triggered the formation of rod-shaped VCP aggregates that
effectively sequester VCP-Venus from the sarcoplasm (Figure 5C). The formation of these aggregates
is striking, as they resemble rod-like structures characteristic of prion aggregates. We considered two
possible reasons that application of DBeQ might increase the propensity for VCP to aggregate. First,
DBeQ binding to VCP might initiate aggregation directly by altering the solubility of VCP.
Alternatively, the aggregation could be caused by the functions of VCP in other contexts, such as
proteasome-dependent protein degradation. Remarkably, when we applied the proteasome inhibitor
MG132, VCP-Venus rapidly aggregated in a manner identical to that observed following DBeQ
incubation (Figure 5D). VCP aggregation was not due to increased VCP protein levels as a result of
proteasome inhibition, because total VCP protein did not increase significantly upon MG132 or DBeQ
treatment (Figure 5E).
While the significance of VCP-Venus aggregates remains uncertain, this phenotype provided us
with a means to rapidly and reversibly sequester VCP protein and control its access to auto-lysosomal
membranes. Since VCP exists as a hexamer, MG132 incubation in muscles over-expressing VCP-Venus
should sequester both wild type and Venus-tagged VCP. Application of MG132 induced VCP-Venus
aggregate formation, which correlated with dissolution of the tubular lysosomal network (Figure 5D).
When MG132 was washed out, VCP aggregates dissolved within 20 min and, as they disappeared,
cytoplasmic VCP fluorescence intensity increased (Figure 5F and Video 6). During this time,
cytoplasmic VCP-Venus accumulated at autophagosomes/lysosomes (mCherry-Atg8a) and tubules
began to reform (Figure 5F and Video 6). These data indicate that VCP localizes to auto-lysosomes,
where it could participate in auto-lysosomes tubulation.
Disrupted lysosome tubules correlate with muscle weakness and
autophagy/lysosome defects
We next investigated the consequence of disrupting the auto-lysosome tubule network. We first
examined overall muscle function. When VCP RNAi was expressed specifically in muscle, muscle
Video 5. Spin-GFP and mCherry-Atg8a dynamics in
Drosophila muscle. Representative time-lapse video of
Spin-GFP and mCherry-Atg8 co-expressed in muscles.
Frames were taken at 10 s intervals.
DOI: 10.7554/eLife.07366.011
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Figure 5. VCP co-localizes with the tubular auto-lysosomes. (A) Representative live image of VCP-Venus and Spin-
RFP expressed in muscles using the muscle-specific BG57-Gal4 driver. White box indicates region shown at higher
magnification and separate channels at right. (B) Representative live image of VCP-Venus and mCherry-Atg8a
expressed in muscles using the muscle-specific BG57-Gal4 driver. Inset as in A. (C, D) VCP-Venus and mCherry-
Atg8a localization in muscles treated with the VCP inhibitor DBeQ (C) or the proteasome inhibitor MG132 (D) for 3
hr. (E) Western blot analysis of total VCP protein levels from muscles in the treatments indicated. Tubulin serves as
a loading control. (F) Representative time-lapse sequence of VCP-Venus and mCherry-Atg8a after MG132 was
washed out. The arrow indicates a tubule extending from a mCherry-Atg8a positive vesicle.
DOI: 10.7554/eLife.07366.012
Figure 5. continued on next page
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wasting was apparent and third instar larvae exhibited a severe impairment in their ability to move
(Figure 6—figure supplement 1A,B). When prodded, the animals would move, but their movements
were slow and only lasted for short periods of time. The defect in their motility is not due to defects in
the nervous system because synaptic transmission at the NMJ remained intact (Figure 6—figure
supplement 1C,D). These data are consistent with compromised muscle function that parallels the
muscle weakness observed in human VCP-related diseases.
Next, we investigated the degradation capacity of the collapsed tubular lysosomes. For lysosomes
to degrade their cargo they must be acidified and the proteolytic enzymes must be present. We first
examined the acidification of the lysosomes by co-imaging Spin-GFP with Lysotracker in VCP-RNAi
animals and found that the enlarged Spin-GFP vesicles also co-stained with Lysotracker
(Figure 6—figure supplement 2A), indicating that they are acidic. Then, we examined whether
lysosome enzymes were delivered properly to the lysosomes. Normally, the lysosomal enzyme
Cathepsin-L is proteolytically processed in the lysosomal lumen to form a mature enzyme. To further
examine the functionality of the lysosomes, we examined processing of Cathepsin-L and found no
significant difference in Cathepsin-L processing in VCP-RNAi animals or animals treated with DBeQ
(Figure 6—figure supplement 1B). Thus, disruption of the tubular lysosomal network does not
appear to affect the proteolytic capacity of sarcoplasmic lysosomes.
To this point, our data suggest that loss of VCP disrupts the fusion of autophagosomes with
functional lysosomes and, in parallel, causes the collapse of the tubular lysosomal network. Based on
this, we expected to find evidence of failed autophagy in VCP knockdown muscle. In wild type
muscles stained with a poly-ubiquitin antibody, we observed small puncta around the nucleus and
a few small puncta in the cytoplasm (Figure 6A). These small puncta likely represent active sites of
protein degradation by the proteasome. However, in muscles expressing VCP-RNAi we observed
a dramatic accumulation of cytoplasmic poly-ubiquitin aggregates (Figure 6B). Even acute treatment
with DBeQ was sufficient to produce cytoplasmic poly-ubiquitin aggregates (Figure 6C–E). We also
note that VCP inhibition caused a dramatic de-
crease in poly-ubiquitin conjugates around the
nucleus, which likely reflects failed delivery of
poly-ubiquitinated proteins to the proteasome.
Importantly, we find that Spin-positive lysosomes
are devoid of poly-ubiquitin staining (Figure 6F),
an observation that is consistent with our model
of failed fusion of autophagosomes with
lysosomes.
In addition to clearing protein aggregates
from the cytoplasm, autophagy is also responsi-
ble for clearing damaged organelles, including
mitochondria. We examined the functional pool
of muscle mitochondria in vivo using mitotracker-
Orange CM-H2TMRos, which selectively stains
mitochondria with an active membrane potential.
Muscles expressing VCP-RNAi displayed less
mitotracker-Orange CM-H2TMRos staining and
the visualized mitochondria had an altered
morphology, appearing round and dispersed
rather than being densely packed, tubular struc-
tures (Figure 6G,H). The swollen mitochondria
observed in the VCP RNAi expressing muscles
Figure 5. Continued
The following figure supplement is available for figure 5:
Figure supplement 1. VCP-Venus localization in Drosophila muscle.
DOI: 10.7554/eLife.07366.013
Video 6. VCP-Venus and mCherry-Atg8a dynamics
after MG132 wash out. Muscles co-expressing VCP-
Venus and mCherry-Atg8 were treated with the pro-
teasome inhibitor MG132 for 3 hr. MG132 was washed
out and time-lapse images were taken every 10 s.
DOI: 10.7554/eLife.07366.014
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are likely defective and should be a prime target for mitophagy-dependent degradation. Taken
together with the appearance of polyubiquitin aggregates, these data are consistent with an overall
defect in autophagic clearance of proteins and defective organelles. However, since VCP has also
Figure 6. Disruption of the tubular auto-lysosomal network correlates with increased poly-Ubiquitin aggregates,
impaired mitochondria and increased lipofuscin granules. (A, B) Wild type (A) and VCP-RNAi (B) expressing muscles
were fixed and stained with a poly-Ubiquitin antibody. Nuclei with localized poly-Ubiquitin staining are apparent in
A. Nuclei are indicated (dashed circle) in B. (C, D) Wild type animals were treated with DMSO (C) or the VCP-specific
inhibitor DBeQ (D), fixed and stained with a poly-Ubiquitin antibody. (E) Quantitation of the number of poly-
Ubiquitin aggregates per 50 μm2 from wild type muscles treated with DMSO for 4 hr or DBeQ for various times
(n = 9, *p < 0.05, **p < 0.01). (F) Localization of Spin-GFP and poly-Ubiquitin in muscles expressing VCP-RNAi. (G, H)
Mitotracker-C2TMRos staining in control (G) and VCP-RNAi (H) muscles. (I–K) Autofluoresence at 488 nm and
lysotracker staining in wild type (I), muscles expressing VCP-RNAi (J), and wild type muscles treated with the VCP-
specific inhibitor DBeQ for 4 hr (K).
DOI: 10.7554/eLife.07366.015
The following figure supplements are available for figure 6:
Figure supplement 1. Loss of tubular lysosomes correlates with impaired muscle function.
DOI: 10.7554/eLife.07366.016
Figure supplement 2. Lysosomal acidity and Cathepsin processing are maintained in VCP-RNAi expressing
muscles.
DOI: 10.7554/eLife.07366.017
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been shown to be recruited directly to damaged mitochondria (Kim et al., 2013) we cannot rule out
the possibility that the effects on mitochondrial morphology and membrane potential are due to
direct VCP functions at the mitochondrial outer membrane.
Finally, we noted an accumulation of lipofuscin granules in VCP-RNAi expressing muscles.
Lipofuscin granules are a conglomerate of polymerized non-degradable proteins and lipids that build
up in the lysosomal lumen (Szweda et al., 2003). A distinguishing property of lipofuscin granules is
that they exhibit auto-fluorescence at 488 nm. Wild type or VCP-RNAi muscles were stained with
LysoTracker-Red and imaged at both 488 nm (green) and 555 nm (magenta). The wild type muscles
did not display any detectable auto-fluorescence at 488 nm (Figure 6I). But, we observed strong auto-
fluorescent puncta in VCP-RNAi that co-localized with LysoTracker (Figure 6J), indicative of lipofuscin
granules. We did not observe autofluorescent puncta to the same extent when wild type muscles were
treated with DBeQ for 4 hr (Figure 6K), suggesting that lipofuscin accumulation is a progressive
phenotype. Alternatively, lipofuscin granule accumulation could require loss of VCP protein rather
than just loss of VCP catalytic activity. These data suggest that maintaining the structural integrity of
lysosome tubules is critical for lysosome function.
VCP-related disease mutations disrupt lysosome tubules
Finally, we asked whether overexpression of VCP transgenes that harbor disease-causing mutations
impairs the presence or dynamics of tubular lysosomes. To date, a total of 19 missense mutations in 13
different residues are associated with IBMFD that reside in either the Cdc48 homology domain, the L1
linker domain or the D1 ATPase domain (Figure 7A and [Ju and Weihl, 2010]). We selected one
mutation from each of these three domains to examine the effect on lysosome tubules: R155H, R191Q
and A232E. R155 is the most common hereditary mutation and is located in the CDC48 homology
domain, which is a protein interaction module that plays an important role in VCP substrate binding
(Ju and Weihl, 2010). R191 is located in the linker region between the CDC48 domain and the first
ATPase catalytic domain (D1). A232 is located at the beginning the of the D1 domain and is the most
severe clinical mutation (Watts et al., 2004). All three residues are conserved in the Drosophila
protein (Figure 7A). As a control, we show that over-expression of wild type dVCP does not alter
tubular lysosomes (Figure 7B). We then demonstrate that over-expression of each of the mutant VCP
transgenes profoundly impairs the tubular lysosomal network (Figure 7C–F). In parallel, we find an
increase in sarcoplasmic auto-fluorescence when these VCP mutants are over-expressed
(Figure 7B–G). Overexpression of the A229E mutation, which is the most severe clinical mutation,
caused the largest increase in auto-fluorescence compared to the other clinical mutations (Figure 7F).
Because over-expression of the disease relevant VCP transgenes phenocopies VCP-RNAi expression,
these data suggest that the disease mutations are dominant interfering mutations. Thus, over-
expression of VCP disease-associated mutations disrupts lysosome tubules in vivo, an effect that
causes accumulation of cytoplasmic lipofuscin granules.
Discussion
Here we demonstrate that lysosomes form a dynamic, tubular array that extends throughout the
sarcoplasm of Drosophila muscle, in vivo. To our knowledge, this is the first observation of such an
extensive, dynamic tubular lysosomal network in any in vivo system. We define this as a lysosomal
network because it has a low pH, it is labeled by the late endosomal marker Spin-GFP, does not co-
localize with the ER, golgi apparatus, early endosomes or recycling endosomes, and we find that
mCherry-Atg8 traffics to this compartment, indicative of autophagosome fusion with a network of
tubular lysosomes. Lysosomal network dynamics require an intact microtubule cytoskeleton, clathrin
heavy chain, and VCP. We provide evidence that the catalytic activity of VCP is continuously required
to sustain network integrity. When VCP is depleted or inhibited, the lysosomal network collapses and
both cellular proteostasis and autophagy are compromised. Collapse of the network correlates with
cellular manifestations of VCP-associated degenerative diseases, including the appearance of protein
inclusion bodies (Kimonis et al., 2008;Weihl et al., 2009). While many questions remain unanswered,
our discovery of tubular lysosome dysfunction following overexpression of pathogenic VCP mutants
represents one the earliest markers of VCP-dependent muscle pathology. Further characterization
could pave the way toward methods that might beneficially stabilize lysosomal function and
ameliorate the progression of widespread degenerative disease.
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Role of an extended tubular lysosome network in muscles
In most tissues, autophagy is induced upon nutrient starvation, but muscles are one of the unique
tissues in which autophagy occurs in the absence of starvation (Mizushima et al., 2004). In fact, basal
autophagy is required to maintain muscle mass (Masiero et al., 2009). The constitutive levels of
autophagy in muscle are likely related to the large energy requirement of muscles compared to other
cell types and their ability to serve as a source of metabolic energy for other organs (Sandri, 2010).
Muscle sarcoplasms are also unique in that they are shared between multiple nuclei and are much
larger in volume compared to many other cell types. We propose that the observed extended,
lysosomal network that is maintained by VCP is a cellular solution to ensure highly efficient autophagy
throughout the entirety of muscle sarcoplasms. It is as if the lysosomes vascularize the sarcoplasm,
ensuring that no portion of the sarcoplasm is ever far from a lysosomal depot where autophagic cargo
can be degraded. Likewise, this network could facilitate the local recycling of nutrients throughout the
sarcoplasm to effectively meet local demands. A similar argument can be made regarding the
autophagy-dependent turnover of mitochondria, which are densely distributed throughout the
Figure 7. Pathogenic VCP alleles disrupt the tubular auto-lysosomal network. (A) Schematic diagram of VCP protein.
Top: Human pathogenic VCPmutations are labeled on the cartoon. Bottom: sequence alignment of human VCP and
Drosophila VCP/Ter94 pathogenic mutant regions. (B–F) Autofluoresence at 488 nm and lysotracker staining in wild
type muscles expressing VCP-WT (B), VCP-RNAi (C) VCP-R152H (D), VCP-R188Q (E) or VCPA-229E (F) transgenes.
(G) Quantitation of the number of auto-fluorescent puncta per 50 μm2 in the genotypes indicated (n = 9, *p < 0.05,
**p < 0.01).
DOI: 10.7554/eLife.07366.018
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muscle. In support of this, VCP is critical for the rapid degradation of muscle proteins during muscle
atrophy and expression of a dominant negative form of VCP reduces protein degradation by both
proteasomes and lysosomes (Piccirillo and Goldberg, 2012).
Lysosomal membranes have been observed to extend tubules and fission off to produce de novo
lysosomes following fusion of autophagosomes with lysosomes (Yu et al., 2010). This process, termed
ALR, serves as a mechanism to recycle lysosomes when autophagic demand is high (Yu et al., 2010). It
is unknown whether ALR is a constitutive process that participates in ongoing, steady-state
proteostasis in vivo or whether it is a process that is specifically induced following stress-induced
autophagy. It is possible that the extended, dynamic lysosomal tubule network that we observe is
related to ALR, perhaps acting as a platform for efficient ALR throughout the sarcoplasm. In support
of this, the mammalian Spinster homolog is required for ALR (Rong et al., 2011). However, the
relatively low frequency with which we observed scission events and the formation of new small
lysosome vesicles is not entirely consistent with this idea.
The tubular network identified in this study more closely resembles the lysosome tubular networks
that have been observed in cultured macrophage cells (Swanson et al., 1987a, 1987b; Knapp and
Swanson, 1990). Macrophage lysosome tubules can form a web of tubules that appear to be stably
connected throughout the cytoplasm (Swanson et al., 1987b). The purpose of lysosome tubules in
this system is still mysterious. We have now identified specific defects associated with loss of lysosome
tubules and our data suggest that the tubular network may distribute auto-lysosomal activity
throughout the cell. Clues to the function of tubular lysosomes might also be gleaned from studies of
early endosomes. Early endosomes form vesicular-tubular structures similar to what we have observed
here (Huotari and Helenius, 2011). In early endosomes it has been established that tubules can
be discrete membrane compartments with a different lipid composition and cargo compared to
that within the vesicular body of the early endosome (Huotari and Helenius, 2011). By analogy,
the ability of lysosomes to exist in a tubular-vesicular state in cellular contexts where their
functional demand is high, might allow lysosomes to execute diverse functions more efficiently
through compartmentalization.
Consequences of tubular lysosome dysfunction
VCP and the yeast homologue Cdc48 have been ascribed many functions within the cell including cell
cycle progression (Moir et al., 1982), UPS and ERAD protein degradation (Meyer et al., 2012; Wolf
and Stolz, 2012), mitophagy (Taylor and Rutter, 2011) and classical autophagy (Ju et al., 2009; Tresse
et al., 2010a; Dargemont and Ossareh-Nazari, 2012;Meyer et al., 2012). VCP achieves these diverse
activities, in part, through its generalized function as an ubiquitin-dependent ‘segregase’ that
dissociates protein conjugates tagged with ubiquitin from protein complexes and organelle membranes
(Halawani and Latterich, 2006; Meyer et al., 2012). For each process that relies upon VCP activity,
different cofactors control VCP localization and function (Baek et al., 2013). To this list of VCP-mediated
activities, we now add the action of VCP in controlling the integrity and dynamics of a tubular lysosomal
system and fusion of autophagosomes with tubular lysosomes. Additional, future experimentation will
be necessary to determine which specific VCP-mediated molecular mechanism(s) is most directly
relevant to the integrity and dynamics of lysosomal tubules in muscle.
The phenotypic consequences following the loss or inhibition of VCP in Drosophila muscle include
the collapse of the tubular lysosomal network, failed fusion of autophagosomes with lysosomes,
accumulation of sarcoplasmic poly-ubiquitin aggregates, accumulation of lipofuscin granules,
impaired mitochondria and impaired muscle health. All of these phenotypes are hallmarks of
degenerative diseases that are associated with mutations in VCP (Watts et al., 2004). We can now
ascribe some of these phenotypes to the action of VCP at lysosomal membranes. Our data indicate
that VCP localizes to autolysosomes and loss of VCP causes collapse of the tubular lysosomal network
and failed autophagosome-lysosome fusion. Furthermore, when previously sequestered VCP is
released back into the cytoplasm, VCP translocates to dormant autolysosomes and tubulation ensues.
Although we cannot distinguish the role of VCP in the initiation and/or maintenance of lysosome
tubules, these data argue that VCP acts at the autolysosmal membrane to control autolysosomal
dynamics and the progression of autophagic protein clearance. If VCP is necessary for normal activity
of the autophagy-lysosome system in muscle as our data suggests, then it seems likely that the
accumulation of poly-ubiquitin aggregates and lipofuscin granules are a direct consequence of
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impaired VCP-dependent lysosomal function. This assertion is further supported by our demonstra-
tion that over-expression of pathogenic VCPmutant transgenes disrupt the tubular lysosomal network
and also cause accumulation of ubiquitin and lipofuscin material. Importantly, these transgenes in
Drosophila do not appear to disrupt VCP roles in the UPS or ERAD pathways, emphasizing the role of
impaired autophagy in pathogenic VCP phenotypes (Tresse et al., 2010b; Chang et al., 2011). We
acknowledge that lipofuscin granule accumulation following overexpression of pathogenic VCP
mutant transgenes could represent a byproduct of proteotoxic stress caused by defects in the UPS or
autophagy/lysosome pathways that eventually lead to the transformation of proteins into non-
degradable products. Ultimately, more detailed biochemical analyses will be required to elucidate
precisely how VCP functions at lysosome membranes and how this activity might be coordinated with
other aspects of VCP function throughout the cell. Taken together, our identification of tubular
lysosomes in Drosophila muscle challenges the traditional view of vesicular lysosomes and suggests
that lysosome structures can be more versatile than previously assumed. Understanding how
lysosomes regulate their morphological state will be an exciting avenue for future studies.
Materials and methods
Experimental procedures
Fly stocks
The following transgenic fly stocks were generated in this study: UAS-Spin-RFP, UAS-Spin-GFP and
UAS-Ter94/VCP-Venus. Drosophila spinster and ter94 cDNA were obtained by amplifying from DGRC
(Drosophlia Genomics Resource Center, Bloomington, IN) clones AT25382 and GM02885 respectively.
The cDNAs were cloned into the Gateway pENTR vector (Invitrogen, South San Francisco, CA) and
subsequently cloned into destination vector pTWV obtained from the Drosophila Gateway Vector
Collection (Carnegie Institution, Baltimore, MD). Transgenic animals were then generated by BestGene.
UAS-mCherry-Atg8a and UAS-GFP-mCherry-Atg8a stocks were purchased from the Bloomington Stock
Center. UAS-RNAi stocks were purchased from the Vienna Drosophila Resource Center. Pathogeneic
UAS-Ter94 alleles were a kind gift from TK Sang (National Tsing Hua University, Hsinchu, Taiwan). Golgi
markers UAS-ManII-GFP and UAS-GalT-YFP were a kind gift from B Ye (University of Michigan, Ann
Arbor, MI). Gal4 muscle drivers used in this study include: BG57-Gal4 and MHC-Gal4.
Microscopy methods
Third instar larvae were dissected in Schneider’s insect cell media (Gibco, Grand Island, NY)
supplemented with 10% FBS (Gibco) and Penicillin/Streptomycin (Gibco) and all live imaging was
performed in insect cell media. For all imaging experiment, at least 3 muscles in 3 animals were
imaged to account for variances between muscles and animals and the most representative images
are shown in each figure (n ≥ 9). The following drugs were diluted in insect cell media to the following
final concentrations: 1uM LysoTracker Red DND-99 (Life Technologies, South San Francisco, CA), 1uM
ER Tracker green (Life Technologies), 10uM Nocodazole (Sigma, St. Louis, MO), 10uM Latrunculin A
(Life Technologies), 10uM DBeQ (Sigma), 1uM MG132 (Sigma), 100 nM Concanamycin A (Santa Cruz
Biotechnology, Dallas, TX), 2ug/ml TM (Sigma) and 500 nM Mitotracker-Orange-CM-H2TMRos (Life
Technologies). LysoTracker, ER Tracker and Mitotracker-Orange-CM-H2TMRos were incubated on
the dissected larvae for 1 hr prior to imaging. Nocodazole, LatA, DBeQ, TM, Concanamycin A and
MG132 were incubated on the dissected larvae for 3–4 hr prior to imaging.
For Ubiquitin staining, larvae were dissected and fixed with 4% PFA for 15 min. After fixation,
larvae were washed 4× with PBS-T and incubated with anti-poly-Ubiquitin (Thermo Scientific,
Waltham, MA) at 1:1000 dilution overnight at 4˚C. Larvae were washed again 4× with PBS-T,
incubated with a fluorescently labeled secondary antibody at 1:5000 dilution (Life Technologies), and
washed again 4× with PBS-T before mounting on a slide with vectashield for imaging.
Imaging was performed on an inverted Axiovert 200 microscope (Zeiss) using a 100× Plan
Apochromat objective (1.4NA). Images were captured with a CoolSnap HQ2 CCD camera
(Photometrics) and de-convolved using Slidebook 5.0 software (Intelligent imaging innovations,
Denver, CO). Image quantification was performed with imageJ software (NIH). Volume rendering was
performed with Slidebook 5.0 software. Any adjustment of brightness or contrast was performed
using Slidebook 5.0 software, and always applied to the entire image.
Johnson et al. eLife 2015;4:e07366. DOI: 10.7554/eLife.07366 17 of 20
Research article Cell biology | Neuroscience
Western blotting methods
Third instar larvae were dissected and muscle preparations were immediately transferred into 5× SDS
sample buffer and denatured by boiling for 10 min. Proteins were resolved by SDS-PAGE on a 4–12%
Bis-Tris gel (Life Technologies), transferred to a nitrocellulose membrane, immunoblotted with
primary and HRP-conjugated secondary antibodies (Life Technologies) and detected using an ECL
chemi-luminescent reagent (Life Technologies). The following primary antibodies were used: anti-VCP
(Cell Signaling, Danvers, MA) at 1:1000, anti- GRP78/HSPA5 (Thermo Scientific) at 1:2500, insect anti-
Cathepsin L (R&D Systems, Minneapolis, MN) at 1:1000, and anti-Tubulin E7-c (Developmental
Studies Hybridoma Bank, University of Iowa, IA) at 1:10,000. Secondary HRP conjugated antibodies
(GE Lifesciences, Pittsburgh, PA) were used at 1:5000.
Electrophysiology methods
Sharp-electrode recordings were made from muscle 6 in abdominal segments 2 and 3 from third-
instar larvae using an Axoclamp 900A amplifier (Molecular Devices), as described previously (Frank
et al., 2006). Recordings were made in HL3 saline containing the following components: NaCl (70
mM), KCl (5 mM), MgCl2 (10 mM), NaHCO3 (10 mM), sucrose (115 mM), trehalose (5 mM), HEPES (5
mM), and CaCl2 (0.3 mM). Mean EPSP, mEPSP amplitude, and Rin were obtained by averaging values
across all NMJs for a given genotype. EPSP traces were analyzed with custom-written routines in
MATLAB (Mathworks, Natick, MA) as previously described (Gavin˜o et al., 2015). mEPSP traces were
analyzed in IGOR Pro 6.3 (Wave-Metrics; custom script submitted with this manuscript).
Acknowledgements
We thank members of the Davis lab for helpful advice and critically reading the manuscript. We are
grateful to Kevin Ford and Ryan Jones for providing custom scripts for EPSP and mEPSP analyses. We
also thank TK Sang and B Ye for generously sharing fly stocks. AEJ is a fellow of the Jane Coffin Childs
Memorial Fund for Medical Research. This study was supported by NIH grant NS047342 to GWD.
Additional information
Competing interests
GWD: Reviewing editor, eLife. The other authors declare that no competing interests exist.
Funding
Funder Grant reference Author
National Institutes of Health R37NS047342 Graeme W Davis
Jane Coffin Childs Memorial Fund
for Medical Research
Postdoctoral Fellowship Alyssa E Johnson
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
AEJ, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or
revising the article; HS, Conception and design, Acquisition of data, Analysis and interpretation of
data; AGH, Acquisition of data, Analysis and interpretation of data; AT, Contributed unpublished
essential data or reagents; GWD, Conception and design, Drafting or revising the article
References
Abramzon Y, Johnson JO, Scholz SW, Taylor JP, Brunetti M, Calvo A, Mandrioli J, Benatar M, Mora G, Restagno G,
Chio` A, Traynor BJ. 2012. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis.
Neurobiology of Aging 33:2231. doi: 10.1016/j.neurobiolaging.2012.04.005.
Baek GH, Cheng H, Choe V, Bao X, Shao J, Luo S, Rao H. 2013. Cdc48: a swiss army knife of cell biology. Journal of
Amino Acids 2013:183421. doi: 10.1155/2013/183421.
Chang YC, Hung WT, Chang YC, Chang HC, Wu CL, Chiang AS, Jackson GR, Sang TK. 2011. Pathogenic VCP/
TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in
a Drosophila IBMPFD model. PLOS Genetics 7:e1001288. doi: 10.1371/journal.pgen.1001288.
Johnson et al. eLife 2015;4:e07366. DOI: 10.7554/eLife.07366 18 of 20
Research article Cell biology | Neuroscience
Chou TF, Brown SJ, Minond D, Nordin BE, Li K, Jones AC, Chase P, Porubsky PR, Stoltz BM, Schoenen FJ, Patricelli
MP, Hodder P, Rosen H, Deshaies RJ. 2011. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent
and autophagic protein clearance pathways. Proceedings of the National Academy of Sciences of USA 108:
4834–4839. doi: 10.1073/pnas.1015312108.
Clemen CS, Tangavelou K, Strucksberg KH, Just S, Gaertner L, Regus-Leidig H, Stumpf M, Reimann J, Coras R,
Morgan RO, Fernandez MP, Hofmann A, Mu¨ller S, Schoser B, Hanisch FG, Rottbauer W, Blu¨mcke I, von Ho¨rsten
S, Eichinger L, Schro¨der R. 2010. Strumpellin is a novel valosin-containing protein binding partner linking
hereditary spastic paraplegia to protein aggregation diseases. Brain 133:2920–2941. doi: 10.1093/brain/awq222.
Cornelissen T, Haddad D, Wauters F, Van Humbeeck C, Mandemakers W, Koentjoro B, Sue C, Gevaert K, De
Strooper B, Verstreken P, Vandenberghe W. 2014. The deubiquitinase USP15 antagonizes Parkin-mediated
mitochondrial ubiquitination and mitophagy. Human Molecular Genetics 23:5227–5242. doi: 10.1093/hmg/ddu244.
Dargemont C, Ossareh-Nazari B. 2012. Cdc48/p97, a key actor in the interplay between autophagy and ubiquitin/
proteasome catabolic pathways. Biochimica Et Biophysica Acta 1823:138–144. doi: 10.1016/j.bbamcr.2011.
07.011.
Dermaut B, Norga KK, Kania A, Verstreken P, Pan H, Zhou Y, Callaerts P, Bellen HJ. 2005. Aberrant lysosomal
carbohydrate storage accompanies endocytic defects and neurodegeneration in Drosophila benchwarmer. The
Journal of Cell Biology 170:127–139. doi: 10.1083/jcb.200412001.
Diaper DC, Adachi Y, Lazarou L, Greenstein M, Simoes FA, Di Domenico A, Solomon DA, Lowe S, Alsubaie R,
Cheng D, Buckley S, Humphrey DM, Shaw CE, Hirth F. 2013. Drosophila TDP-43 dysfunction in glia and muscle
cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Human Molecular Genetics
22:3883–3893. doi: 10.1093/hmg/ddt243.
Dolan PJ, Jin YN, Hwang W, Johnson GV. 2011. Decreases in valosin-containing protein result in increased levels of
tau phosphorylated at Ser262/356. FEBS Letters 585:3424–3429. doi: 10.1016/j.febslet.2011.09.032.
Frank CA, Kennedy MJ, Goold CP, Marek KW, Davis GW. 2006. Mechanisms underlying the rapid induction and
sustained expression of synaptic homeostasis. Neuron 52:663–677. doi: 10.1016/j.neuron.2006.09.029.
Gavin˜o MA, Ford KJ, Archila S, Davis GW. 2015. Homeostatic synaptic depression is achieved through a regulated
decrease in presynaptic calcium channel abundance. eLife 4:e05473. doi: 10.7554/eLife.05473.
Gonzalez MA, Feely SM, Speziani F, Strickland AV, Danzi M, Bacon C, Lee Y, Chou TF, Blanton SH, Weihl CC,
Zuchner S, Shy ME. 2014. A novel mutation in VCP causes Charcot-Marie-Tooth type 2 disease. Brain 137:
2897–2902. doi: 10.1093/brain/awu224.
Halawani D, Latterich M. 2006. p97: the cell’s molecular purgatory? Molecular Cell 22:713–717. doi: 10.1016/j.
molcel.2006.06.003.
Huotari J, Helenius A. 2011. Endosome maturation. The EMBO Journal 30:3481–3500. doi: 10.1038/emboj.
2011.286.
Huss M, Ingenhorst G, Ko¨nig S, Gassel M, Dro¨se S, Zeeck A, Altendorf K, Wieczorek H. 2002. Concanamycin A, the
specific inhibitor of V-ATPases, binds to the V(o) subunit c. The Journal of Biological Chemistry 277:40544–40548.
doi: 10.1074/jbc.M207345200.
Ju JS, Weihl CC. 2010. Inclusion body myopathy, Paget’s disease of the bone and fronto-temporal dementia:
a disorder of autophagy. Human Molecular Genetics 19:R38–R45. doi: 10.1093/hmg/ddq157.
Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC. 2009. Valosin-containing
protein (VCP) is required for autophagy and is disrupted in VCP disease. The Journal of Cell Biology 187:
875–888. doi: 10.1083/jcb.200908115.
Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A, Smith RB, Ritson GP, Winborn
BJ, Moore J, Lee JY, Yao TP, Pallanck L, Kundu M, Taylor JP. 2013. VCP is essential for mitochondrial quality
control by PINK1/Parkin and this function is impaired by VCP mutations.Neuron 78:65–80. doi: 10.1016/j.neuron.
2013.02.029.
Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS,
Tucker S, Kimonis K, Mumm S, Whyte MP, Smith CD, Watts GD. 2008. Clinical studies in familial VCP myopathy
associated with Paget disease of bone and frontotemporal dementia. American Journal of Medical Genetics. Part
A 146A:745–757. doi: 10.1002/ajmg.a.31862.
Knapp PE, Swanson JA. 1990. Plasticity of the tubular lysosomal compartment in macrophages. Journal of Cell
Science 95:433–439.
Latterich M, Fro¨hlich KU, Schekman R. 1995. Membrane fusion and the cell cycle: Cdc48p participates in the fusion
of ER membranes. Cell 82:885–893. doi: 10.1016/0092-8674(95)90268-6.
Liewluck T, Milone M, Mauermann ML, Castro-Couch M, Cerhan JH, Murthy NS. 2014. A novel VCP mutation
underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers. Muscle
Nerve 50:295–299. doi: 10.1002/mus.24290.
Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M.
2009. Autophagy is required to maintain muscle mass. Cell Metabolism 10:507–515. doi: 10.1016/j.cmet.2009.
10.008.
Meyer H, Bug M, Bremer S. 2012. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nature
Cell Biology 14:117–123. doi: 10.1038/ncb2407.
Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. 2004. In vivo analysis of autophagy in response to
nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Molecular Biology of
the Cell 15:1101–1111. doi: 10.1091/mbc.E03-09-0704.
Moir D, Stewart SE, Osmond BC, Botstein D. 1982. Cold-sensitive cell-division-cycle mutants of yeast: isolation,
properties, and pseudoreversion studies. Genetics 100:547–563.
Johnson et al. eLife 2015;4:e07366. DOI: 10.7554/eLife.07366 19 of 20
Research article Cell biology | Neuroscience
Nezis IP, Shravage BV, Sagona AP, Lamark T, Bjørkøy G, Johansen T, Rusten TE, Brech A, Baehrecke EH, Stenmark
H. 2010. Autophagic degradation of dBruce controls DNA fragmentation in nurse cells during late Drosophila
melanogaster oogenesis. The Journal of Cell Biology 190:523–531. doi: 10.1083/jcb.201002035.
Piccirillo R, Goldberg AL. 2012. The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation
of muscle proteins. The EMBO Journal 31:3334–3350. doi: 10.1038/emboj.2012.178.
Ralston E, Ploug T, Kalhovde J, Lomo T. 2001. Golgi complex, endoplasmic reticulum exit sites, and microtubules
in skeletal muscle fibers are organized by patterned activity. The Journal of Neuroscience 21:875–883.
Ren C, Finkel SE, Tower J. 2009. Conditional inhibition of autophagy genes in adult Drosophila impairs immunity
without compromising longevity. Experimental Gerontology 44:228–235. doi: 10.1016/j.exger.2008.10.002.
Rong Y, McPhee CK, McPhee C, Deng S, Huang L, Chen L, Liu M, Tracy K, Baehrecke EH, Baehreck EH, Yu L,
Lenardo MJ. 2011. Spinster is required for autophagic lysosome reformation and mTOR reactivation following
starvation. Proceedings of the National Academy of Sciences of USA 108:7826–7831. doi: 10.1073/pnas.
1013800108.
Rong Y, Liu M, Ma L, Du W, Zhang H, Tian Y, Cao Z, Li Y, Ren H, Zhang C, Li L, Chen S, Xi J, Yu L. 2012. Clathrin and
phosphatidylinositol-4,5-bisphosphate regulate autophagic lysosome reformation. Nature Cell Biology 14:
924–934. doi: 10.1038/ncb2557.
Sandri M. 2010. Autophagy in skeletal muscle. FEBS Letters 584:1411–1416. doi: 10.1016/j.febslet.2010.01.056.
Swanson J, Burke E, Silverstein SC. 1987a. Tubular lysosomes accompany stimulated pinocytosis in macrophages.
The Journal of Cell Biology 104:1217–1222. doi: 10.1083/jcb.104.5.1217.
Swanson J, Bushnell A, Silverstein SC. 1987b. Tubular lysosome morphology and distribution within macrophages
depend on the integrity of cytoplasmic microtubules. Proceedings of the National Academy of Sciences of USA
84:1921–1925. doi: 10.1073/pnas.84.7.1921.
Sweeney ST, Davis GW. 2002. Unrestricted synaptic growth in spinster-a late endosomal protein implicated in
TGF-beta-mediated synaptic growth regulation. Neuron 36:403–416. doi: 10.1016/S0896-6273(02)01014-0.
Szweda PA, Camouse M, Lundberg KC, Oberley TD, Szweda LI. 2003. Aging, lipofuscin formation, and free
radical-mediated inhibition of cellular proteolytic systems. Ageing Research Reviews 2:383–405. doi: 10.1016/
S1568-1637(03)00028-X.
Taylor EB, Rutter J. 2011. Mitochondrial quality control by the ubiquitin-proteasome system. Biochemical Society
Transactions 39:1509–1513. doi: 10.1042/BST0391509.
Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP. 2010a. VCP/p97 is essential for
maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause
IBMPFD. Autophagy 6:217–227. doi: 10.4161/auto.6.2.11014.
Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP. 2010b. VCP/p97 is essential
for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause
IBMPFD. Autophagy 6:217–227. doi: 10.4161/auto.6.2.11014.
Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. 2009. Valosin containing
protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
Neuromuscular Disorders 19:766–772. doi: 10.1016/j.nmd.2009.08.003.
Wang Y, Ballar P, Zhong Y, Zhang X, Liu C, Zhang YJ, Monteiro MJ, Li J, Fang S. 2011. SVIP induces localization of
p97/VCP to the plasma and lysosomal membranes and regulates autophagy. PLOS ONE 6:e24478. doi: 10.1371/
journal.pone.0024478.
Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. 2004.
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by
mutant valosin-containing protein. Nature Genetics 36:377–381. doi: 10.1038/ng1332.
Weihl CC, Pestronk A, Kimonis VE. 2009. Valosin-containing protein disease: inclusion body myopathy with Paget’s
disease of the bone and fronto-temporal dementia. Neuromuscular Disorders 19:308–315. doi: 10.1016/j.nmd.
2009.01.009.
Wo´jcik C, Rowicka M, Kudlicki A, Nowis D, McConnell E, Kujawa M, DeMartino GN. 2006. Valosin-containing
protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-
fusion degradation pathway substrates in mammalian cells. Molecular Biology of the Cell 17:4606–4618.
Wolf DH, Stolz A. 2012. The Cdc48 machine in endoplasmic reticulum associated protein degradation. Biochimica
Et Biophysica Acta 1823:117–124. doi: 10.1016/j.bbamcr.2011.09.002.
Xie Z, Klionsky DJ. 2007. Autophagosome formation: core machinery and adaptations. Nature Cell Biology 9:
1102–1109. doi: 10.1038/ncb1007-1102.
Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, Mi N, Zhao Y, Liu Z, Wan F, Hailey DW, Oorschot V,
Klumperman J, Baehrecke EH, Lenardo MJ. 2010. Termination of autophagy and reformation of lysosomes
regulated by mTOR. Nature 465:942–946. doi: 10.1038/nature09076.
Johnson et al. eLife 2015;4:e07366. DOI: 10.7554/eLife.07366 20 of 20
Research article Cell biology | Neuroscience
